| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0004 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.1 | 0.0006 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.003 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.004 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.093 | 0.004 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.004 |